Lab-grown cell clusters regrow tiny heart vessels
After a heart attack, small blood vessels in heart tissue are lost permanently. Surgeons can replace large vessels, but the tiny microvessels that sustain the heart muscle from within remain out of reach. A new approach using laboratory-grown cell clusters may change that.
Researchers created vascular organoids, small aggregates of cells capable of forming new blood vessels, using endothelial progenitor cells from human blood and smooth muscle cells derived from human bone marrow stem cells. The study describes how patches of these organoids were placed on the outer surface of pig hearts with ischemic heart disease and monitored for four weeks.
The results were encouraging. Heart function improved in pigs receiving the organoid patches compared to untreated animals. Progression toward heart failure was slowed. Individual cells from the surface patches were found in deeper layers of the heart tissue, suggesting active migration into the muscle and potential contribution to new vessel formation.
Why this matters for aging
The broader relevance extends beyond heart disease. Loss of capillary density is a recognized feature of aging across many tissues, including muscle, brain, and kidney. If organoid-based strategies can restore microvascular networks, the approach could have implications well beyond cardiac repair. The researchers note this possibility, though translation to other tissues remains speculative at this stage.
The organoid patches survived for several weeks after transplantation. They appear to mimic enough of the function of the extracellular matrix, the structural scaffold that holds cells together in tissue, to improve survival of transplanted cells. This makes the approach mechanistically more robust than simple cell infusion.
What still needs to be shown
The findings are currently limited to an animal model. Pig hearts closely resemble human hearts, which strengthens the translational case, but clinical trials in humans have not yet been conducted. Whether this strategy will prove safe and effective in people requires substantial further research.
Want to research this yourself?
Search for example:
- vascular organoids cardiac regeneration
- capillary rarefaction aging
- endothelial progenitor cell therapy